In vivo studies have shown that when the MATH structural domain of SPOP polypeptide chain was mutated, the protein content of PD-L1 was significantly increased in the tumor tissues of tumor-bearing mice, improving the therapeutic effect of PD-L1 monoclonal antibody. Here, CD274 is linked to neoplasm.